Innate Pharma

Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body’s immune system to recognize and kill cancer cells. The Company’s aim is to become a commercial stage biopharmaceutical company in the area of immunotherapy and focused on serious unmet medical needs in cancer. Innate Pharma has pioneered the discovery and development of checkpoint inhibitors to activate the innate immune system. Innate Pharma's innovative approach has resulted in three first-in-class, clinical-stage antibodies targeting natural killer cell receptors that may address a broad range of solid and hematological cancer indications.
Type
Public
HQ
Marseille, FR
Founded
1999
Employees
127 (est)
Innate Pharma was founded in 1999 and is headquartered in Marseille, FR

Key People at Innate Pharma

Marcel ROZENCWEIG

Marcel ROZENCWEIG

CMO
Hervé BRAILLY

Hervé BRAILLY

CEO

Innate Pharma Locations

Marseille, FR

Innate Pharma Metrics

Innate Pharma Summary

Market capitalization

€725 M

Closing share price

€13.4
Innate Pharma's latest market capitalization is €725 M.

Innate Pharma Market Value History

Innate Pharma News

Innate Pharma Company Life

You may also be interested in